PRF Technologies (PRFX) Tax Provisions (2021 - 2025)
PRF Technologies (PRFX) posted Tax Provisions of $263000.0 for Q2 2025, up 1.54% on a QoQ basis from $259000.0 in Q4 2024, and up 3.14% year-over-year from $255000.0 in Q2 2024.
PRF Technologies (PRFX) Tax Provisions (2021 - 2025) Analysis & Trends
PRF Technologies' Tax Provisions history runs 5 years deep, the most recent figure standing at $263000.0 for Q2 2025.
- Quarterly Tax Provisions rose 3.14% year-over-year to $263000.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $263000.0 (up 3.14% YoY) and the FY2025 annual result came in at $8000.0, down 96.91% from the prior year.
- Tax Provisions was $263000.0 for Q2 2025 at PRF Technologies, up from $259000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $263000.0 in Q2 2025 and bottomed at $213000.0 in Q1 2021.
- A 5-year average of $242125.0 and a median of $244000.0 in 2022 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2022 — Tax Provisions increased 10.8% — and 2025, when it gained 3.14%.
- PRF Technologies' Tax Provisions stood at $234000.0 in 2021, then grew by 3.85% to $243000.0 in 2022, then grew by 3.29% to $251000.0 in 2023, then gained by 3.19% to $259000.0 in 2024, then increased by 1.54% to $263000.0 in 2025.
- Business Quant data shows PRFX's Tax Provisions at $263000.0 in Q2 2025, $259000.0 in Q4 2024, and $255000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 67.00 Mn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 157.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 676.90 Mn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 43.40 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | -423.70 Mn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 48.90 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 30.00 Mn |
| 10 | PRF Technologies | 714,066.24 | -326,933.76 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 263,000.00 |
| Dec 31, 2024 | 259,000.00 |
| Jun 30, 2024 | 255,000.00 |
| Mar 31, 2024 | 253,000.00 |
| Dec 31, 2023 | 251,000.00 |
| Sep 30, 2023 | 249,000.00 |
| Jun 30, 2023 | 247,000.00 |
| Mar 31, 2023 | 245,000.00 |
| Dec 31, 2022 | 243,000.00 |
| Sep 30, 2022 | 240,000.00 |
| Jun 30, 2022 | 238,000.00 |
| Mar 31, 2022 | 236,000.00 |
| Dec 31, 2021 | 234,000.00 |
| Sep 30, 2021 | 228,000.00 |
| Jun 30, 2021 | 220,000.00 |
| Mar 31, 2021 | 213,000.00 |